DEUTSCHE BANK AG\
BankPosition in EWTX — Edgewise Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in EWTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,954,146
+$2,965,305 QoQ
Shares Held
244,995
+10.4% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 223 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. EWTX ranks #44 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in EWTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,954,146 | 244,995 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $6,988,841 | 221,868 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $5,329,492 | 214,769 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,512,412 | 154,896 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,934,052 | 147,525 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,273,320 | 376,060 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $7,364,847 | 275,837 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $5,815,269 | 217,882 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $560,362 | 31,114 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $460,997 | 25,274 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $223,285 | 20,410 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $120,885 | 21,097 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $138,880 | 17,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $157,391 | 23,597 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $148,734 | 16,637 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $118,709 | 12,064 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $111,877 | 14,055 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $213,361 | 21,996 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $374,267 | 24,494 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $122,342 | 7,370 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $156,668 | 7,345 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||